EE70 Real-World Comparison of Healthcare Resource Utilization and Costs Between Patients with Chronic Lymphocytic Leukemia Treated with First-Line Ibrutinib or Acalabrutinib
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.342
https://www.valueinhealthjournal.com/article/S1098-3015(23)03472-1/fulltext
Title :
EE70 Real-World Comparison of Healthcare Resource Utilization and Costs Between Patients with Chronic Lymphocytic Leukemia Treated with First-Line Ibrutinib or Acalabrutinib
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03472-1&doi=10.1016/j.jval.2023.09.342
First page :
Section Title :
Open access? :
No
Section Order :
12366